The emerging approach of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment